Purpose of the Test
- Monitor patient response to Tyrosine Kinase Inhibitor (TKI) therapy.
- Early detection of molecular relapse.
- Measure Major Molecular Response (MMR) levels.
Book BCR-ABL PCR Test in Saudi Arabia | Lahalak Medical Platform
A precise molecular test to monitor treatment efficacy in Chronic Myeloid Leukemia patients, detecting residual cancer cells with high sensitivity to ensure long-term health stability and optimal clinical response.
Scientific name: BCR-ABL Quantitative PCR for Chronic Myeloid Leukemia
This test measures BCR-ABL1 transcript levels in the blood using quantitative PCR. It is essential for assessing drug response and adjusting treatment plans for CML patients to ensure disease control.
Service type
Laboratory test
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- Blood sample collection
- Quantitative PCR analysis
- Laboratory results report
Medical Service Information
Target Groups
- Patients diagnosed with Chronic Myeloid Leukemia (CML).
- Patients undergoing bone marrow transplantation.
- Individuals requiring periodic genetic monitoring.
Frequently Asked Questions
- Does the test require fasting? No, fasting is not necessary.
- How often is the test performed? Usually every 3 months during initial treatment.
- Is home service available? Yes, blood collection can be done at your home.
Conditions & Notices
- Preferably performed at regular intervals every 3 months as directed by the physician
Medical services you might also like
